WASHINGTON — If Democrats are spoiling for a 2020 fight focused on anything besides impeaching President Trump, consider this week’s vote on a massive drug pricing package their opening salvo.
House Speaker Nancy Pelosi’s Lower Drug Costs Now Act, a sweeping bill that pledges to lower consumer drug costs by 50%, includes ideas long touted by progressives in Washington: It would let Medicare directly negotiate the price of at least 50 drugs per year and it would cap U.S. drug payments based on costs in other developed countries.
Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!
GET STARTEDWhat is it?
STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.
What's included?
- Daily reporting and analysis
- The most comprehensive industry coverage from a powerhouse team of reporters
- Subscriber-only newsletters
- Daily newsletters to brief you on the most important industry news of the day
- STAT+ Conversations
- Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
- Exclusive industry events
- Premium access to subscriber-only networking events around the country
- The best reporters in the industry
- The most trusted and well-connected newsroom in the health care industry
- And much more
- Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.
About the Author Reprints
